The MERIDIEN Study is a prospective, multi-center, double-blind, randomized (1:1), sham-controlled, cross-over study to evaluate the safety and efficacy of the NEUROMARK™ System in patients with Chronic Rhinitis.
A randomized, sham-controlled, double-blind study of the NEUROMARKTM system as a treatment for chronic rhinitis